Class | Name/Company | Approval Dates and Comments |
Photodynamic |
DUSA Pharmaceuticals |
The US FDA approved Levulan PDT in December 1999, for the |
Anticancer Agents |
Genta Inc |
The US FDA granted fast-track |
Antibacterial Agents |
Bayer |
An advisory committee to the |
Antifungal |
Hoechst-Marion Roussel |
The US FDA approved this nail lacquer in December 1999, for the |
Keratolytic Agents |
Dermik Laboratories |
An NDA was submitted in October 1999, for a treatment using |
Anticancer |
Vical Inc |
The US FDA granted orphan drug designation to this drug in |
Drug News | ||
Anorectal |
Pivotal Phase III trial results for nitroglycerin ointment (Anogesic) were released in November 1999. They |
|
OTC Products |
The US FDA issued a final rule in September 1999, that all OTC drug products containing colloidal silver or |
|
HIV and AIDS |
Researchers at the National Institute of Allergy and Infectious Diseases hypothesize that HIV may continue |
|
Hair Growth |
The US FDA’s pharmacy compounding committee in November 1999, recommended against including |